Skip to main content
Clinical Trials/NCT02818478
NCT02818478
Completed
Not Applicable

Patient Reported Outcome Measures Reported Into the Danish Arthritis Registry (DANBIO) Via Computer or Tablet at Home Versus Touch Screen at the Outpatient Clinic Among Patients With Axial Spondyloarthritis or Rheumatoid Arthritis

Henrik Gudbergsen0 sites42 target enrollmentMay 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rheumatoid Arthritis
Sponsor
Henrik Gudbergsen
Enrollment
42
Primary Endpoint
HAQ
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

To investigate if electronic reporting of patient reported outcome measures from home is comparable to the traditional touch-screen solution to hospital among patients with rheumatoid arthritis and axial spondyloarthritis

Registry
clinicaltrials.gov
Start Date
May 2016
End Date
December 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Henrik Gudbergsen
Responsible Party
Sponsor Investigator
Principal Investigator

Henrik Gudbergsen

EU Project Coordinator

Parker Research Institute

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

HAQ

Time Frame: 48 hours

The Health Assessment Questionnaire (HAQ) developed to retrieve quantitative information on outcomes among patients with rheumatoid arthritis

Secondary Outcomes

  • 100 mm VAS global(48 hours)
  • 100 mm VAS pain(48 hours)
  • 100 mm VAS fatigue(48 hours)
  • BASDAI(48 hours)
  • BASFI(48 hours)
  • BASDAI 5 & 6(48 hours)

Similar Trials